Report Detail

Pharmaceuticals & Healthcare Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome) - Pipeline Review, H2 2018

  • RnM2427059
  • |
  • 19 September, 2018
  • |
  • Global
  • |
  • 74 pages
  • |
  • Global Markets Direct
  • |
  • Pharmaceuticals & Healthcare

Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome) - Pipeline Review, H2 2018

Table of Contents

    List of Tables

      List of Figures

        Introduction

          Global Markets Direct Report Coverage

            Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome) - Overview

              Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome) - Therapeutics Development

                Pipeline Overview

                  Pipeline by Companies

                    Pipeline by Universities/Institutes

                      Products under Development by Companies

                        Products under Development by Universities/Institutes

                          Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome) - Therapeutics Assessment

                            Assessment by Target

                              Assessment by Mechanism of Action

                                Assessment by Route of Administration

                                  Assessment by Molecule Type

                                    Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome) - Companies Involved in Therapeutics Development

                                      Astellas Pharma Inc

                                        Idera Pharmaceuticals Inc

                                          Kyorin Pharmaceutical Co Ltd

                                            Kytogenics Pharmaceuticals Inc

                                              Lipella Pharmaceuticals Inc

                                                UCB SA

                                                  Urigen Pharmaceuticals Inc

                                                    Xigen SA

                                                      Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome) - Drug Profiles

                                                        Antisense Oligonucleotide to Inhibit NLRP3 for Interstitial Cystitis and Uveitis - Drug Profile

                                                          Product Description

                                                            Mechanism Of Action

                                                              R&D Progress

                                                                ASP-6294 - Drug Profile

                                                                  Product Description

                                                                    Mechanism Of Action

                                                                      R&D Progress

                                                                        brimapitide - Drug Profile

                                                                          Product Description

                                                                            Mechanism Of Action

                                                                              R&D Progress

                                                                                certolizumab pegol - Drug Profile

                                                                                  Product Description

                                                                                    Mechanism Of Action

                                                                                      R&D Progress

                                                                                        dimethyl sulfoxide - Drug Profile

                                                                                          Product Description

                                                                                            Mechanism Of Action

                                                                                              R&D Progress

                                                                                                F-16357 - Drug Profile

                                                                                                  Product Description

                                                                                                    Mechanism Of Action

                                                                                                      R&D Progress

                                                                                                        GM-0111 - Drug Profile

                                                                                                          Product Description

                                                                                                            Mechanism Of Action

                                                                                                              R&D Progress

                                                                                                                lidocaine - Drug Profile

                                                                                                                  Product Description

                                                                                                                    Mechanism Of Action

                                                                                                                      R&D Progress

                                                                                                                        LP-08 - Drug Profile

                                                                                                                          Product Description

                                                                                                                            Mechanism Of Action

                                                                                                                              R&D Progress

                                                                                                                                mesalamine - Drug Profile

                                                                                                                                  Product Description

                                                                                                                                    Mechanism Of Action

                                                                                                                                      R&D Progress

                                                                                                                                        NEO-5937 - Drug Profile

                                                                                                                                          Product Description

                                                                                                                                            Mechanism Of Action

                                                                                                                                              R&D Progress

                                                                                                                                                onabotulinumtoxinA - Drug Profile

                                                                                                                                                  Product Description

                                                                                                                                                    Mechanism Of Action

                                                                                                                                                      R&D Progress

                                                                                                                                                        pentosan polysulfate sodium - Drug Profile

                                                                                                                                                          Product Description

                                                                                                                                                            Mechanism Of Action

                                                                                                                                                              R&D Progress

                                                                                                                                                                Stem Cell Therapy for Interstitial Cystitis and Metabolic Disorders - Drug Profile

                                                                                                                                                                  Product Description

                                                                                                                                                                    Mechanism Of Action

                                                                                                                                                                      R&D Progress

                                                                                                                                                                        URG-801 - Drug Profile

                                                                                                                                                                          Product Description

                                                                                                                                                                            Mechanism Of Action

                                                                                                                                                                              R&D Progress

                                                                                                                                                                                Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome) - Dormant Projects

                                                                                                                                                                                  Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome) - Discontinued Products

                                                                                                                                                                                    Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome) - Product Development Milestones

                                                                                                                                                                                      Featured News & Press Releases

                                                                                                                                                                                        Sep 27, 2016: Idera Pharmaceuticals Presents New Third Generation Antisense (3GA) Data at the 12th Annual Meeting of the Oligonucleotide Therapeutics Society

                                                                                                                                                                                          Aug 27, 2015: Lipella Pharmaceuticals Announces Enrollment of First Patient in Phase-2 Trial in Interstitial Cystitis

                                                                                                                                                                                            Appendix

                                                                                                                                                                                              Methodology

                                                                                                                                                                                                Coverage

                                                                                                                                                                                                  Secondary Research

                                                                                                                                                                                                    Primary Research

                                                                                                                                                                                                      Expert Panel Validation

                                                                                                                                                                                                        Contact Us

                                                                                                                                                                                                          Disclaimer

                                                                                                                                                                                                          Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome) - Pipeline Review, H2 2018

                                                                                                                                                                                                          Summary

                                                                                                                                                                                                          Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Interstitial Cystitis (Painful Bladder SyndromeBladder Pain Syndrome) - Pipeline Review, H2 2018, provides an overview of the Interstitial Cystitis (Painful Bladder SyndromeBladder Pain Syndrome) (Central Nervous System) pipeline landscape.

                                                                                                                                                                                                          Interstitial cystitis also called painful bladder syndrome is a chronic condition in which person experience bladder pressure, bladder pain and sometimes pelvic pain, ranging from mild discomfort to severe pain. Symptoms include decreased bladder capacity, painful sexual intercourse, chronic pelvic pain and a persistent, urgent need to urinate. Risk factors include age, gender and chronic pain disorder, such as irritable bowel syndrome or fibromyalgia. Treatment includes non-steroidal anti-inflammatory drug, antidepressants and antihistamines.

                                                                                                                                                                                                          Report Highlights

                                                                                                                                                                                                          Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Interstitial Cystitis (Painful Bladder SyndromeBladder Pain Syndrome) - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Interstitial Cystitis (Painful Bladder SyndromeBladder Pain Syndrome) (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

                                                                                                                                                                                                          The Interstitial Cystitis (Painful Bladder SyndromeBladder Pain Syndrome) (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Preclinical and Discovery stages are 2, 3, 8 and 1 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 1 molecules, respectively.

                                                                                                                                                                                                          Interstitial Cystitis (Painful Bladder SyndromeBladder Pain Syndrome) (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

                                                                                                                                                                                                          Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

                                                                                                                                                                                                          Scope
                                                                                                                                                                                                          - The pipeline guide provides a snapshot of the global therapeutic landscape of Interstitial Cystitis (Painful Bladder SyndromeBladder Pain Syndrome) (Central Nervous System).
                                                                                                                                                                                                          - The pipeline guide reviews pipeline therapeutics for Interstitial Cystitis (Painful Bladder SyndromeBladder Pain Syndrome) (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
                                                                                                                                                                                                          - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
                                                                                                                                                                                                          - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
                                                                                                                                                                                                          - The pipeline guide reviews key companies involved in Interstitial Cystitis (Painful Bladder SyndromeBladder Pain Syndrome) (Central Nervous System) therapeutics and enlists all their major and minor projects.
                                                                                                                                                                                                          - The pipeline guide evaluates Interstitial Cystitis (Painful Bladder SyndromeBladder Pain Syndrome) (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
                                                                                                                                                                                                          - The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
                                                                                                                                                                                                          - The pipeline guide reviews latest news related to pipeline therapeutics for Interstitial Cystitis (Painful Bladder SyndromeBladder Pain Syndrome) (Central Nervous System)

                                                                                                                                                                                                          Reasons to buy

                                                                                                                                                                                                          - Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
                                                                                                                                                                                                          - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
                                                                                                                                                                                                          - Find and recognize significant and varied types of therapeutics under development for Interstitial Cystitis (Painful Bladder SyndromeBladder Pain Syndrome) (Central Nervous System).
                                                                                                                                                                                                          - Classify potential new clients or partners in the target demographic.
                                                                                                                                                                                                          - Develop tactical initiatives by understanding the focus areas of leading companies.
                                                                                                                                                                                                          - Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
                                                                                                                                                                                                          - Formulate corrective measures for pipeline projects by understanding Interstitial Cystitis (Painful Bladder SyndromeBladder Pain Syndrome) (Central Nervous System) pipeline depth and focus of Indication therapeutics.
                                                                                                                                                                                                          - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
                                                                                                                                                                                                          - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.


                                                                                                                                                                                                          Summary:
                                                                                                                                                                                                          Get latest Market Research Reports on Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome). Industry analysis & Market Report on Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome) is a syndicated market report, published as Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome) - Pipeline Review, H2 2018. It is complete Research Study and Industry Analysis of Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


                                                                                                                                                                                                          REPORT YOU MIGHT BE INTERESTED

                                                                                                                                                                                                          Purchase this Report

                                                                                                                                                                                                          $2,000.00
                                                                                                                                                                                                          $4,000.00
                                                                                                                                                                                                          $6,000.00
                                                                                                                                                                                                          1,602.69
                                                                                                                                                                                                          3,205.38
                                                                                                                                                                                                          4,808.07
                                                                                                                                                                                                          1,783.25
                                                                                                                                                                                                          3,566.51
                                                                                                                                                                                                          5,349.76
                                                                                                                                                                                                          215,720.00
                                                                                                                                                                                                          431,440.00
                                                                                                                                                                                                          647,160.00
                                                                                                                                                                                                          137,792.80
                                                                                                                                                                                                          275,585.60
                                                                                                                                                                                                          413,378.40
                                                                                                                                                                                                          Credit card Logo

                                                                                                                                                                                                          Related Reports


                                                                                                                                                                                                          Reason to Buy

                                                                                                                                                                                                          Request for Sample of this report